Overview
To understand whether psilocybin, a naturally occurring psychedelic substance, can help improve symptoms of sadness, depression, quality of life, hopelessness, and function in adults with ALS. Over approximately 8 months, participants will have about 15 meetings with the research team including psilocybin dosing sessions.
